FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations

Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.